Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Debt / NOTE 0.599% 8/0
-
Unit price / market price
-
$1.05
-
Total 13F principal
-
$434,741,990
-
Principal change
-
+$6,577,090
-
Total reported value
-
$456,373,728
-
Number of holders
-
49
-
Value change
-
+$2,093,914
-
Number of buys
-
19
-
Number of sells
-
23
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q3 2020
As of 30 Sep 2020 BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 had 49 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $434,741,990 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included MACKAY SHIELDS LLC, ADVENT CAPITAL MANAGEMENT /DE/, LAZARD ASSET MANAGEMENT LLC, PFM Health Sciences, LP, Allianz Asset Management GmbH, SHENKMAN CAPITAL MANAGEMENT INC, MORGAN STANLEY, BAKER BROS. ADVISORS LP, STATE STREET CORP, and Man Group plc.
This table shows 49 bond principal holders of the security as of 30 Sep 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.